Team
Francisco Campos Pérez
Group coordinator
Dr. Francisco Campos has more than 15 years of experience in the field of neuroscience, 8 of them in cerebrovascular pathologies. He completed his postdoctoral training at the IIBB-CSIC (Barcelona) (2007-08), at the Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) (2009-10) and at the Massachusetts General Hospital-Harvard Medical School (2011-12). In 2013, he returned to the Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) obtaining, in 2015, a stable position as Miguel Servet Researcher, the highest professional category in biomedical research in Spain. He is currently the coordinator of the Stroke Translational Group (TRAET Group) at IDIS. In the last 10 years, Dr. Campos has participated as co-author in more than 100 international and original articles in the main neuroscience journals (Stroke, Annals of Neurology, JCBFM or Neurology), being first or corresponding author in 50 of them. He has participated as principal investigator in more than 10 research projects supported by public and private funding; 4 national projects (funded by ISCIII) and 3 European projects. In the last 5 years, Dr. Campos has coordinated more than 4M€ of funding. In the academic field, Dr. Campos has also been the supervisor of 11 international theses.
OUR TEAM
Project Manager
Gustavo Rama
Project Manager
Gustavo Rama
Project Manager
Gustavo Rama holds a PhD in Chemical Biology from the University of Santiago de Compostela and a Master's in Clinical Trials Monitoring and Medical Affairs. Senior researcher in Life Sciences and a passionate advocate for scientific and technological advancements, with wide experience in Chemical Biology and Materials Science research. He completed his two-year postdoctoral stay at the prestigious Carnegie Mellon University (Pitt, PA, USA) to work on the development of a sepsis sensor based on Peptide Nucleic Acids (PNAs).
Dr. Gustavo Rama has extensive training and great experience in Project and Personnel Management, which he acquired throughout his professional career in the different laboratories he worked in.
OUR TEAM
Basic Researchers
Ana Bugallo Casal
PhD Student
Ana Bugallo Casal
PhD Student
Ana Bugallo Casal studied Biology at the University of Santiago de Compostela (USC), where she also completed a master's degree in R&D of Medicines obtaining the Extraordinary Prize of their graduating class. Currently, she is a doctoral student in the TREAT group (IDIS) and is developing her thesis under a PFIS contract sponsored by Instituto de Salud Carlos III (ISCIII, fellowship reference: PI17/00540) in the context of a rare disease known as Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL).
María Candamo-Lourido
PhD Student
María Candamo-Lourido
PhD Student
BSc in Biochemistry at University of Extremadura in 2019, MSc in Cellular and Molecular Pathophisiology and Pharmacology at University of Salamanca in 2020. On the same year, she joins the TREAT neurosience laboratory. In 2021 she obtains a predoctoral fellowship from Xunta de Galicia. Her research is focused on the study of brain tumour metabolism and the search for new targets for glioblastoma treatment.
Clara Correa-Paz
PhD
Clara Correa-Paz
PhD
I held a degree in Pharmacy and a Master in Neuroscience from the University of Santiago de Compostela. In 2019 I completed my PhD thesis titled “Optimization of thrombolytic therapy in brain pathology”, which was carried out in the Clinical Neuroscience Research Laboratory of the Health Research Institute of Santiago de Compostela, through a pre-doctoral grant for the training of doctors (FPI) from the Ministerio de Ciencia e Innovación. I was awarded cum laude and the Extraordinary Doctorate Award. Currently, I continue my postdoc working in the development of different treatments and nanosystems to improve the thrombolytic treatment in the ischemic stroke.
Lucía del Pozo-Filíu
PhD Student
Lucía del Pozo-Filíu
PhD Student
BSc in Biotechnology at University of Extremadura in 2020, MSc in Neurosciences at University of Salamanca in 2021. She joined the TREAT research group in 2022 thanks to a GAIN doctoral grant to prepare her PhD thesis as part of a new line of research on the role of glutamate in Amyotrophic Lateral Sclerosis (ALS) under the direction of Francisco Campos Pérez, PI of the group, and Julio Pardo Fernández, a neurologist specializing in ALS. This thesis is being prepared within the Doctoral Program in Molecular Medicine at the University of Santiago de Compostela.
Esteban López-Arias
PhD
Esteban López Arias has a degree in Biology, specialized in Cellular and Molecular Biology, is Senior Technician in Pathology and Cytology, Master in Bioinformatics and in Neurosciences, and PhD in Molecular Medicine. His PhD thesis was obtained in University of Santiago de Compostela in 2020 focused in stroke and stem cells and is titled: "Induced pluripotent stem cells as a new approach in therapy for stroke". Currently, he is working in research that evaluates GOT as potential treatment for ischemic stroke in preclinical phase. its fields of work are animal models, cell cultures, biochemical and immunological techniques, magnetic resonance acquisition and imaging, optical microscopy, and flow cytometry-sorting.
Lara Pérez Gayol
Clinical and biomedical laboratory technician
Lara Pérez Gayol
Clinical and biomedical laboratory technician
Graduated in Clinical and Biomedical Laboratory in 2020, and in Pathological Anatomy and Cytodiagnostics in 2021. In the same year she joins the Clinical Neuroscience Laboratory at IDIS.
María Pérez Mato
PhD
María Pérez Mato
PhD
Dr. María Pérez Mato received her PhD in 2015 from the University of Santiago de Compostela. She has extensive experience in animal models of cerebral ischemia, cell culture and flow cytometry. During this period, she worked at the Forschungszentrum Jülich (Germany) in the field of molecular biology and virus production. She has done her postdoctoral training (Sara Borrell CD19/00033) at the Laboratory of Neurosciences and Cerebrovascular Research, coordinated by Dr. Maria Gutierrez. Her main research lines are focus on the discovery of new neuroprotective therapies targeting glutamate excitotoxicity in cerebral ischemia, and the role of extracellular vesicles as biomarkers in patients with intracerebral hemorrhage and ischemic stroke.
Nuria Palomar
Student PhD
Nuria Palomar
Student PhD
Graduated in BSc Biology by the Autonomous University of Madrid and specialized in Biomedical Research (MSc at the University of Santiago de Compostela). After finishing my master studies in 2022, I moved to Seoul (South Korea) for a one-year internship at the Neurodegenerative Disorders Laboratory led by Prof. Kim Manho of the CMI (Center for Medical Innovation), a research center associated with the Seoul National University Hospital. Currently, I am part of the Traslational Stroke Laboratory (TREAT) where I have started my journey as a PhD student.
Fernando Laso García
PhD
Dr. Fernando Laso García obtained his Ph.D. in Neurosciences in 2023 from the Autonomous University of Madrid. He is commencing his post-doctoral research under the Sara Borrell fellowship (CD24/00073), focusing on "Neuroprotection against excitotoxic damage following cerebral ischemia." His doctoral research was conducted in the Laboratory of Neurosciences and Cerebrovascular Research, led by Dr. María Gutiérrez, with a specialization in translational research on brain damage plasticity and repair, neurosonology, neuromodulation, and cerebrovascular diseases.
Noelia Otero
PhD
Noelia Otero
PhD
Graduated in Pathological Anatomy and Cytodiagnosis in 2022, with a specialization in histology, microtomy, immunohistochemistry, and immunofluorescence techniques. In early 2025, she joined the Clinical Neurosciences Laboratory at the Health Research Institute (IDIS), further expanding her experience in the field of biomedical research.neuromodulation, and cerebrovascular diseases.
OUR TEAM
Clinical Researchers
Manuel Rodríguez Yáñez
Doctor of Medicine. Area Specialist Physician (FEA) in Neurology
Susana Arias
Doctor of Medicine. Specialist Area Practitioner (FEA) in Neurology
María Santamaría
Doctor of Medicine and Medical Specialist in Neurology Area
Julio Pardo
Doctor of Medicine and Specialist in Neurology Area
Jesús Prego Domínguez
Doctor of Nursing and Primary Care Nurse
Jesús Prego Domínguez
Doctor of Nursing and Primary Care Nurse
I carried out my scientific activity during my training as a researcher, both in the Master in Public Health that I completed in the 2012-2013 academic year, and in the subsequent PhD in Epidemiology and Public Health, both completed at the University of Santiago de Compostela.
In my first job, I studied the relationship between hematological cancer and paracetamol consumption through a meta-analysis, in which I found a positive relationship between the two.
Subsequently, I focused my research activity on the risk factors of chronic pain, a disease with a great population impact, which generates a high demand for care both in primary and specialized care and of enormous relevance as a public health problem.
In this area, I have carried out a meta-analysis in which I demonstrated the protective effect of the consumption of polyunsaturated fatty acids on chronic pain. Subsequently, I have focused my research activity on the relationship between social and gender factors and the appearance of chronic pain, seeking an approach focused on the community and the population most vulnerable to this ailment. In my studies, I have identified, both in meta-analyses and in large population-based cohort studies, the relationship between the risk of developing chronic pain and socioeconomic status, workloads, and the burden of home care. In addition, I have studied the way in which sex modifies the relationship between these factors and the probability of developing chronic pain, publishing the first study quantifying this relationship through interaction indicators. Finally, I have also addressed the relationship between these factors and the process of worsening chronic pain, on which hardly any studies have been carried out to date, contributing to increasing knowledge about it, determining how social and gender factors can contribute to the worsening of this ailment once established.
Finally, it is worth noting that the works on chronic pain included in my doctoral thesis presented in 2021, obtained the qualification "cum laude" with International Mention, obtained after carrying out a research stay at the Karolinska Institutet in Stockholm, in which I developed the studies on the public health cohort of the city.
Currently, I work as a full-time care nurse in Primary Care, the Ordes Health Center, of the Integrated Management Area of Santiago de Compostela and Barbanza, belonging to the Servizo Galego de Saúde (SERGAS); position to which I have been linked since 1997 and from which I propose this research project.
In summary, both my scientific and academic activity, mostly focused on chronic pain and during which I acquired knowledge and experience in the development and analysis of epidemiological studies, as well as my professional activity in Primary Care, where I have contact with and knowledge of first-hand information on the target population of this study, justify my experience in the subject matter and type of project that I propose.
Antonio Cañizo Outeiriño
PhD
Antonio Cañizo Outeiriño is a pharmacist specialized in Hospital Pharmacy and, since 2025, also serves as a Río Hortega researcher (ISCIII). He is currently pursuing a PhD in Drug Research and Development at the University of Santiago de Compostela. His research focuses on personalized medicine in ophthalmic diseases, with a specific emphasis on the identification of predictive biomarkers of treatment response and the discovery of new therapeutic targets through the use of advanced proteomic techniques.
OUR TEAM
Students
Sofía Pérez Quintanilla
Student
Sofía Pérez Quintanilla
Student
Student in the last year of the Biology degree at the University of Santiago de Compostela. She did her compulsory internship at the Translational Stroke (TREAT) group at IDIS in 2024.

